|
| | Publication Year | Title | Author(s) |
| 1 | Feb-2024 | Variability of bone marrow biopsy reporting affects accuracy of diagnosis of myeloproliferative neoplasms: data from the ALLG MPN01 registry. | Ng, Wei Yang; Erber, Wendy N; Grigg, Andrew P ; Dunne, Karin; Perkins, Andrew; Forsyth, Cecily; Ross, David M |
| 2 | 10-Jan-2024 | Arsenic-induced neurotoxicity in patients with acute promyelocytic leukaemia. | Loh, Zoe ; Ashby, Michael; Van Veldhuizen, Ellie; Li, Wenlong; Chee, Ashlyn; Aung, Winpa; Lavrukhina, Yelena; Mason, George; Pelly, Tenille; Nedumannil, Rithin; Kosciejew, Serena; Mokoonlall, Mridula; Lim, Jonathan; Calov, Georgina; Butler, Llewyn; Hillebrand, Paulina; Beekman, Ashley; Rathnasekara, Greasha Kalani; Raj, Sonia; Zhang, Cathey; Yao, Yao; Iland, Harry; Grigg, Andrew P |
| 3 | Dec-2023 | Significant heterogeneity in management of calreticulin-mutated essential thrombocythemia and its progression to myelofibrosis: results of a national survey. | Murton, Alexandra; Forsyth, Cecily; Ross, David M; Grigg, Andrew P |
| 4 | 28-Nov-2023 | Phase 3 SELENE Study: Ibrutinib Plus BR/R-CHOP in Previously Treated Patients with Follicular or Marginal Zone Lymphoma. | Nastoupil, Loretta J; Hess, Georg; Pavlovsky, Miguel Arturo; Danielewicz, Iwona; Freeman, Jane A; Martin Garcia-Sancho, Alejandro; Glazunova, Valeria; Grigg, Andrew P ; Hou, Jing-Zhou; Janssens, Ann; Kim, Seok-Jin; Masliak, Zvenyslava; McKay, Pamela; Merli, Francesco; Munakata, Wataru; Nagai, Hirokazu; Özcan, Muhit; Preis, Meir; Wang, Tingyu; Rowe, Melissa; Tamegnon, Monelle; Qin, Rui; Henninger, Todd; Curtis, Madeliene; Caces, Donne Bennett; Thieblemont, Catherine; Salles, Gilles A |
| 5 | 5-Oct-2023 | Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1. | Crosswell, Howland E; LaCasce, Ann S; Bartlett, Nancy L; Straus, David J; Savage, Kerry J; Zinzani, Pier Luigi; Collins, Graham P; Fanale, Michelle; Fenton, Keenan; Dong, Cassie; Miao, Harry; Grigg, Andrew P |
| 6 | 1-Sep-2023 | Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention. | Shanmuganathan, Naranie; Wadham, Carol; Shahrin, NurHezrin; Feng, Jinghua; Thomson, Daniel; Wang, Paul; Saunders, Verity; Kok, Chung Hoow; King, Rob M; Kenyon, Rosalie R; Lin, Ming; Pagani, Ilaria S; Ross, David M; Yong, Agnes S M; Grigg, Andrew P ; Mills, Anthony K; Schwarer, Anthony P ; Braley, Jodi; Altamura, Haley; Yeung, David T; Scott, Hamish S; Schreiber, Andreas W; Hughes, Timothy P; Branford, Susan |
| 7 | Aug-2023 | Outcome of an elective readmission policy in patients receiving acute myeloid leukaemia consolidation therapy and implications for an outpatient management programme. | Grigg, Andrew P ; Prabahran, Ashvind; Donati, Vanessa; Wong, Eric ; Mason, Kate |
| 8 | 1-Jul-2023 | Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis. | Kalincik, Tomas; Sharmin, Sifat; Roos, Izanne; Freedman, Mark S; Atkins, Harold; Burman, Joachim; Massey, Jennifer; Sutton, Ian; Withers, Barbara; Macdonell, Richard A L ; Grigg, Andrew P ; Torkildsen, Øivind; Bo, Lars; Lehmann, Anne Kristine; Havrdova, Eva Kubala; Krasulova, Eva; Trnený, Marek; Kozak, Tomas; van der Walt, Anneke; Butzkueven, Helmut; McCombe, Pamela; Skibina, Olga; Lechner-Scott, Jeannette; Willekens, Barbara; Cartechini, Elisabetta; Ozakbas, Serkan; Alroughani, Raed; Kuhle, Jens; Patti, Francesco; Duquette, Pierre; Lugaresi, Alessandra; Khoury, Samia J; Slee, Mark; Turkoglu, Recai; Hodgkinson, Suzanne; John, Nevin; Maimone, Davide; Sa, Maria Jose; van Pesch, Vincent; Gerlach, Oliver; Laureys, Guy; Van Hijfte, Liesbeth; Karabudak, Rana; Spitaleri, Daniele; Csepany, Tunde; Gouider, Riadh; Castillo-Triviño, Tamara; Taylor, Bruce; Sharrack, Basil; Snowden, John A; Mrabet, Saloua; Garber, Justin; Sanchez-Menoyo, Jose Luis; Aguera-Morales, Eduardo; Blanco, Yolanda; Al-Asmi, Abdullah; Weinstock-Guttman, Bianca; Fragoso, Yara; de Gans, Koen; Kermode, Allan |
| 9 | Jul-2023 | Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study. | Townsend, William; Hiddemann, Wolfgang; Buske, Christian; Cartron, Guillaume; Cunningham, David; Dyer, Martin J S; Gribben, John G; Phillips, Elizabeth H; Dreyling, Martin; Seymour, John F; Grigg, Andrew P ; Trotman, Judith; Lin, Tong-Yu; Hong, Xiao-Nan; Kingbiel, Dirk; Nielsen, Tina G; Knapp, Andrea; Herold, Michael; Marcus, Robert |
| 10 | May-2023 | Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study. | Manos, Kate ; Chong, Geoffrey ; Keane, Colm; Lee, Sze Ting ; Smith, Charmaine; Churilov, Leonid ; McKendrick, Joseph; Renwick, William; Blombery, Piers; Burgess, Melinda; Nelson, Niles Elizabeth; Fancourt, Tineke ; Hawking, Joanne; Lin, Wendi; Scott, Andrew M ; Barraclough, Allison ; Wight, Joel C ; Grigg, Andrew P ; Fong, Chun Yew ; Hawkes, Eliza A |
| 11 | May-2023 | Targeting the BRAF pathway in haematological diseases. | Rees, Matthew J ; Dickinson, Michael; Paterson, James; Ng, Teng F; Grigg, Andrew P ; Moore, John; Blombery, Piers; Seymour, John F |
| 12 | 20-Apr-2023 | Evaluation of a safe neutrophil count for cessation of intravenous antibiotics and early hospital discharge in stable, afebrile patients recovering after acute myeloid leukemia therapy or an autograft. | Hu, Chih-Chiang; Subramanian, Rakhee; Grigg, Andrew P |
| 13 | 20-Apr-2023 | Fertility recovery after high-dose melphalan containing regimens. | Grigg, Andrew P ; Haran, Harini |
| 14 | 8-Feb-2023 | Disseminated Invasive Mucormycosis Infection Following Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma. | Cliff, Edward R Scheffer; Reynolds, Gemma; Grigg, Andrew P |
| 15 | Feb-2023 | Optimizing the oral dose of cyclosporine with concomitant posaconazole post stem cell allograft. | McClelland, Julia; Wong, Eric ; Grigg, Andrew P |
| 16 | Jan-2023 | Acute kidney injury in patients receiving high-dose etoposide phosphate as conditioning prior to hematopoietic stem cell transplantation in hematologic malignancies may be associated with elevated body mass index. | Stewart, Tamasine; Dowling, Mark; Janson, Brett; Siderov, Jim ; Xie, Jing; Grigg, Andrew P ; Khot, Amit |
| 17 | 2023 | Augmented ICE in Patients With Poor-Risk Refractory and Relapsed Lymphomas. | Loo, Sun; Lim, Andrew Boon Ming ; Lee, Sze Ting ; Grigg, Andrew P |
| 18 | 14-Oct-2022 | Effective Tumor Debulking with Ibrutinib Before Initiation of Venetoclax: Results from the CAPTIVATE Minimal Residual Disease and Fixed-Duration Cohorts. | Barr, Paul M; Tedeschi, Alessandra; Wierda, William G; Allan, John N; Ghia, Paolo; Vallisa, Daniele; Jacobs, Ryan; O'Brien, Susan; Grigg, Andrew P ; Walker, Patricia; Zhou, Cathy; Ninomoto, Joi; Krigsfeld, Gabriel; Tam, Constantine S |
| 19 | 7-Oct-2022 | Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma. | Nath, Christa Ellen; Grigg, Andrew P ; Rosser, Sebastian P A; Estell, Jane; Newman, Elizabeth; Tiley, Campbell; Ramanathan, Sundra; Ho, Shir Jing; Larsen, Stephen; Gibson, John; Presgrave, Peter; Shaw, Peter John; Trotman, Judith |
| 20 | 8-Aug-2022 | Effective Tumor Debulking With Ibrutinib Before Initiation of Venetoclax: Results From the CAPTIVATE Minimal Residual Disease (MRD) and Fixed-Duration (FD) Cohorts. | Barr, Paul M; Tedeschi, Alessandra; Wierda, William G; Allan, John N; Ghia, Paolo; Vallisa, Daniele; Jacobs, Ryan; O'Brien, Susan; Grigg, Andrew P ; Walker, Patricia; Zhou, Cathy; Ninomoto, Joi; Krigsfeld, Gabriel; Tam, Constantine S |
Loading...
2
0
20
0
false